R&D Projects

Confirmed projects database queries

The information may be unavailable due to the results not being approved or confirmed. In particular, when a call includes regions where projects are cofunded by EC funds and others where that is not the case, confirmation or approval may be not simultaneous.

Call for Proposals for Scientific Research and Technological Development Projects in all Scientific Domains - 2010

Health Sciences - Pharmaceutical sciences

Painel de Avaliação da área das Ciências da Saúde - 2010

Robert Hofstra
Christoph Tang
E.M. Hol
Louis Lemieux
Jean-Michel Bouler
Luca Mainardi
Maurice Zeegers
Francisco Bolumar
Stephen Paul Hilary Alexander
Jochen Klein
Ad Geurts van Kessel
Fernando Giraldez Orgaz
Humphrey Hodgson
Geert Martens
Gerard J te Meerman
Maxime GUYE
Bruno Bujoli
Andrew Westwell
Stephen Hiscox
Marc Bracke
Roberto Sassi
Anna Maria Bianchi
Raymond Macallister
Herman Waldmann
Carlos Fitzsimons
Willem Kamphuis
Martin Prins
Dagmar Fischer
Miguel Delgado
Lionel Ginsberg
Derek Macallan

PTDC/SAU-FAR/116535/2010: Non-invasive-Non-viral Silencing of Machado-Joseph disease. LUÍS FERNANDO MORGADO PEREIRA DE ALMEIDA, Centro de Neurociências e Biologia Celular (CNBC/UC). €108,280.
PTDC/SAU-FAR/118459/2010: Towards malaria eradication. A novel approach for multi-targeting the parasite´s life cycle. Francisca Lopes, Faculdade de Farmácia da Universidade de Lisboa (FF/ULisboa). €132,014.
PTDC/SAU-FAR/118787/2010: ARE MICROGLIA A NEW POTENTIAL PHARMACOLOGICAL TARGET IN AMYOTROPHIC LATERAL SCLEROSIS (ALS)? Dora Brites, Faculdade de Farmácia da Universidade de Lisboa (FF/ULisboa). €146,273.
PTDC/SAU-FAR/119173/2010: ArmAb: New strategy of ADC for arming antibodies in cancer therapy. Joao Goncalves, Associação para o Desenvolvimento do Ensino e Investigação da Microbiologia (ADEIM). €99,189.
PTDC/SAU-FAR/119389/2010: TherMelVac- dendritic cell-targeted peptide vaccine against melanoma by ligand-modified nanoparticles. Helena Isabel Fialho Florindo Roque Ferreira, Faculdade de Farmácia da Universidade de Lisboa (FF/ULisboa). €126,649.
PTDC/SAU-FAR/120453/2010: siRNA incorporation in a lipid/micelle-based nanocarrier as a strategy to restore E-cadherin expression and eradicate advanced breast cancer metastatic phenotype. Mafalda de Castro Ascensão Marques Videira, Faculdade de Farmácia da Universidade de Lisboa (FF/ULisboa). €115,809.
PTDC/SAU-FAR/121109/2010: Neuropeptide release in wounds: a new therapeutic approach for the treatment of diabetic foot ulceration. Ermelindo Carreira Leal, Centro de Neurociências e Biologia Celular (CNBC/UC). €128,405.